Prevalence of Autoimmune Gastritis in Individuals Undergoing Medical Checkups in Japan
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Objective Based on both endoscopic findings and serum auto-antibody levels, we determined the prevalence of autoimmune gastritis (AIG), which has not been previously reported, in individuals who underwent health checkup examinations in Japan. Methods At total of 6,739 subjects (4,288 males, 2,451 females; mean age 52.1 years) underwent an upper gastrointestinal endoscopic examination as part of an annual medical checkup. Those suspected to have AIG based on endoscopic evidence of proximal-predominant gastric mucosal atrophy were further examined for the presence of anti-parietal cells and anti-intrinsic factor antibodies, with a final diagnosis of AIG made in cases found to be positive for either or both of those factors. Results Of the 6,739 examined subjects, 46 were suspected to have AIG based on the endoscopic findings, of whom 33 were finally diagnosed with AIG, for an overall prevalence 0.49% (females 0.65%, males 0.40%). Seven with AIG also had thyroid disease, including Hashimoto's and Basedow disease, while none with AIG showed anemia in blood test findings. The prevalence of AIG was not different regardless of the H. pylori infection status (negative, positive, post-eradicated). Conclusion In individuals who underwent an upper gastrointestinal endoscopic examination as part of an annual checkup in Japan, the prevalence of AIG was 0.49%. We concluded that it is not uncommon for asymptomatic and healthy individuals to have AIG, and propose that additional studies are needed to clarify its prevalence as well as to establish the criteria used for diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The prevalence has been estimated to approximate 0.5%–2%, although this might be an overestimation.16–18”
From AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021) · cites this paper as [16]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A reappraisal of the nature and significance of chronic atrophic gastritis
Strickland, R. G., & Mackay, I. R. (1973) · The American Journal of Digestive Diseases · doi:10.1007/bf01071995 · Cited by 584 · cited 2×
“Autoimmune gastritis (AIG), type A gastritis, is a chronic inflammatory disease of the stomach caused by cellular and humoral immune responses to gastric parietal cells (1-3).”
BackgroundToh, B.-H., van Driel, I. R., & Gleeson, P. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711133372007 · Cited by 510
Kass, L. (1976) · Cited by 459
Prevalence of Undiagnosed Pernicious Anemia in the Elderly
Carmel, R. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.10.1097 · Cited by 309 · cited 1×
“No definitive criteria for the diagnosis of AIG have been established and its prevalence in the general population has not been fully determined, though the disease is reported to be more common in women and older individuals (6-8).”
BackgroundAmedei, A., Bergman, M. P., Appelmelk, B. J., Azzurri, A., Benagiano, M., Tamburini, C., van der Zee, R., Telford, J. L., Vandenbroucke-Grauls, C. M. J. E., D'Elios, M. M., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030530 · Cited by 288 · cited 2×
“Serum gastrin, pg/mL 2,255±388 (250-4,700) 722±111 (81-930) 177±56 (10-570) <0.”
BackgroundSystematic review: gastric cancer incidence in pernicious anaemia
Vannella, L., Lahner, E., Osborn, J., & Annibale, B. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12177 · Cited by 235 · cited 2×
“In addition, the incidence of gastric cancer in cases with AIG has been reported to be higher than that in the general population (2, 3, 7, 29).”
BackgroundAutoimmune gastritis: Pathologist’s viewpoint
Coati, I. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i42.12179 · Cited by 214 · cited 3×
“In addition, the incidence of gastric cancer in cases with AIG has been reported to be higher than that in the general population (2, 3, 7, 29).”
BackgroundThe Achlorhydria-Carcinoid Sequence: Role of Gastrin
Creutzfeldt, W. (1988) · Digestion · doi:10.1159/000199609 · Cited by 178 · cited 2×
“Neuroendocrine cell hyperplasia and tumors caused by hypergastrinemia are well-known complications seen in patients with AIG (2, 6, 7, 27, 28).”
BackgroundDiagnosis and classification of autoimmune gastritis
Toh, B. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.048 · Cited by 168 · cited 8×
“Gastric mucosal atrophy in the area of the corpus and fundus gradually progresses in patients with AIG, and loss of parietal cells with disease progression provokes hypoacidity and anacidity (2, 4-6).”
BackgroundInfluentialRationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers
Agréus, L., Kuipers, E. J., Kupcinskas, L., Malfertheiner, P., Di Mario, F., Leja, M., Mahachai, V., Yaron, N., van Oijen, M., Perez Perez, G., et al. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.645501 · Cited by 165 · cited 2×
“Serum gastrin, pg/mL 2,255±388 (250-4,700) 722±111 (81-930) 177±56 (10-570) <0.”
BackgroundHypergastrinemia and gastric enterochromaffin-like cells.
Bordi, C., D’Adda, T., Azzoni, C., Pilato, F. P., & Caruana, P. (1995) · PubMed · Cited by 146
Zhang, Y., Weck, M. N., Schöttker, B., Rothenbacher, D., & Brenner, H. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1343 · Cited by 132 · cited 2×
“Considering the high prevalence of positive results for the anti-parietal cells antibody in serum in previous reports (9, 10), we consider that there may be many undiagnosed individuals with AIG who do not have apparent proximal-predominant gastric mucosal atrophy.”
BackgroundSugimoto, M., Ban, H., Ichikawa, H., Sahara, S., Otsuka, T., Inatomi, O., Bamba, S., Furuta, T., & Andoh, A. (2017) · Internal Medicine · doi:10.2169/internalmedicine.56.7775 · Cited by 132 · cited 2×
“Serum gastrin, pg/mL 2,255±388 (250-4,700) 722±111 (81-930) 177±56 (10-570) <0.”
MethodKulnigg-Dabsch, S. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0515-5 · Cited by 98 · cited 6×
“Inflammation and continuous atrophy is restricted to the corpus and fundus in patients with AIG, since parietal cells are a type of epithelial cell located in glands of the corpus and fundus, but not in the antrum (2, 3).”
BackgroundResultInfluential[Helicobacter pylori infection and endoscopic gastritis -Kyoto classification of gastritis].
鎌田, 智., 春間, 賢., 井上, 和., & 塩谷, 昭. (2015) · 日本消化器病学会雑誌 · doi:10.11405/nisshoshi.112.982 · Cited by 88 · cited 2×
“Serum gastrin, pg/mL 2,255±388 (250-4,700) 722±111 (81-930) 177±56 (10-570) <0.”
MethodWatanabe, K., Nagata, N., Nakashima, R., Furuhata, E., Shimbo, T., Kobayakawa, M., Sakurai, T., Imbe, K., Niikura, R., Yokoi, C., et al. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i27.4374 · Cited by 87 · cited 3×
“Serum gastrin, pg/mL 2,255±388 (250-4,700) 722±111 (81-930) 177±56 (10-570) <0.”
MethodKato, M., Terao, S., Adachi, K., Nakajima, S., Ando, T., Yoshida, N., Uedo, N., Murakami, K., Ohara, S., Ito, M., et al. (2012) · Digestive Endoscopy · doi:10.1111/j.1443-1661.2012.01385.x · Cited by 74 · cited 3×
“Serum gastrin, pg/mL 2,255±388 (250-4,700) 722±111 (81-930) 177±56 (10-570) <0.”
MethodSelf-citationNATURAL HISTORY OF AUTOIMMUNE ACHLORHYDRIC ATROPHIC GASTRITIS A 1-15-year Follow-up Study
Irvine, W. J., Cullen, D. R., & Mawhinney, H. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92013-3 · Cited by 69 · cited 3×
“With disease progression, anacidity, iron deficiency anemia, and pernicious anemia appear in affected individuals (4, 5).”
BackgroundAssociation of autoimmune type atrophic corpus gastritis with Helicobacter pylori infection.
Veijola, L., Oksanen, A. M., Sipponen, P., & Rautelin, H. I. K. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i1.83 · Cited by 68 · cited 2×
“Serum gastrin, pg/mL 2,255±388 (250-4,700) 722±111 (81-930) 177±56 (10-570) <0.”
BackgroundNasrollahzadeh, D., Aghcheli, K., Sotoudeh, M., Shakeri, R., Persson, E. C., Islami, F., Kamangar, F., Abnet, C. C., Boffetta, P., Engstrand, L. G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026957 · Cited by 67 · cited 2×
“Serum gastrin, pg/mL 2,255±388 (250-4,700) 722±111 (81-930) 177±56 (10-570) <0.”
BackgroundHelicobacter pylori infection in subjects negative for high titer serum antibody
Toyoshima, O., Nishizawa, T., Arita, M., Kataoka, Y., Sakitani, K., Yoshida, S., Yamashita, H., Hata, K., Watanabe, H., & Suzuki, H. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i13.1419 · Cited by 56 · cited 1×
“Serum gastrin, pg/mL 2,255±388 (250-4,700) 722±111 (81-930) 177±56 (10-570) <0.”
Antico, A., Tampoia, M., Villalta, D., Tonutti, E., Tozzoli, R., & Bizzaro, N. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/520970 · Cited by 53 · cited 2×
“Serum gastrin, pg/mL 2,255±388 (250-4,700) 722±111 (81-930) 177±56 (10-570) <0.”
BackgroundFactors associated with parietal cell autoantibodies in the general population
de León, A. C., González, D. A., Almeida, A. A., Hernández, A. G., Pérez, M. C., Pérez, M. D. C. R., Gil-Guillén, V. F., & Díaz, B. B. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.06.004 · Cited by 40
Adachi, K., Mishiro, T., Tanaka, S., & Kinoshita, Y. (2016) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.16-13 · Cited by 16 · cited 4×
“pylori antibody J kit (FUJIFILM Wako Pure Chemical Corporation, Osaka) (11-13).”
BackgroundSelf-citationAdachi, K., Mishiro, T., Okimoto, E., & Kinoshita, Y. (2018) · Internal Medicine · doi:10.2169/internalmedicine.1074-18 · Cited by 15 · cited 4×
“pylori antibody J kit (FUJIFILM Wako Pure Chemical Corporation, Osaka) (11-13).”
BackgroundSelf-citationPrevalence of Multiple White and Flat Elevated Lesions in Individuals Undergoing a Medical Checkup
Adachi, K., Mishiro, T., Okada, M., & Kinoshita, Y. (2017) · Internal Medicine · doi:10.2169/internalmedicine.9808-17 · Cited by 12 · cited 4×
“pylori antibody J kit (FUJIFILM Wako Pure Chemical Corporation, Osaka) (11-13).”
BackgroundSelf-citationNoninvasive prediction of chronic atrophic gastritis in autoimmune thyroid disease in primary care
Tursi, A., Grattagliano, I., POLO, M. D., Pirrotta, E., Bacchin, P. G., Picchio, M., & BASTIANI, R. D. (2014) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2014.958097 · Cited by 9 · cited 2×
“Serum gastrin, pg/mL 2,255±388 (250-4,700) 722±111 (81-930) 177±56 (10-570) <0.”
ResultAtrophic Body Gastritis in Patients With Autoimmune Thyroid Disease: An Underdiagnosed Association
Centanni, M., Marignani, M., Gargano, L., Corleto, V. D., Casini, A., Delle Fave, G., Andreoli, M., & Annibale, B. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.15.1726 · Cited by 1 · cited 2×
“Serum gastrin, pg/mL 2,255±388 (250-4,700) 722±111 (81-930) 177±56 (10-570) <0.”
Result
Cited by
AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review
Shah, S. C., Piazuelo, M. B., Kuipers, E. J., & Li, D. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.06.078 · Cited by 560
Lenti, M. V., Rugge, M., Lahner, E., Miceli, E., Toh, B.-H., Genta, R. M., De Block, C., Hershko, C., & Di Sabatino, A. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0187-8 · Cited by 350
The immune microenvironment in gastric adenocarcinoma
Zavros, Y., & Merchant, J. L. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00591-0 · Cited by 188
RE.GA.IN.: the Real-world Gastritis Initiative–updating the updates
Rugge, M., Genta, R. M., Malfertheiner, P., Dinis-Ribeiro, M. J., El‐Serag, H. B., Graham, D. Y., Kuipers, E. J., Leung, W. K., Park, J. Y., Rokkas, T., et al. (2024) · Gut · doi:10.1136/gutjnl-2023-331164 · Cited by 173
Rustgi, S. D., Bijlani, P., & Shah, S. C. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211038771 · Cited by 137
Metadata
- Authors
- Notsu, T., Adachi, K., Mishiro, T., Fujihara, H., Toda, T., Takaki, S., & Kinoshita, Y.
- Affiliations
- Shimane Prefectural Institute of Public Health and Environmental Sciences (JP)
- Clinical Laboratory, Shimane Environment and Health Public Corporation, Japan
- Shimane University (JP)
- Venue
- Internal Medicine
- Published
- 2019-07-01
- Volume
- 58
- Issue
- 13
- Pages
- 1817-1823
- ISSN
- 0918-2918 (ISSN-L)
- 1349-7235
- PMC
- PMC6663548
- OpenAlex
- W2923714055
- Cited by
- 82
- References
- 28
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 10 · 2023: 11 · 2022: 13 · 2021: 10 · 2020: 8 · 2019: 3
- FWCI
- 8.12
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Internal Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Shimane University
- Topics
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Health Sciences › Medicine › Gastroenterology › Celiac Disease Research and Management
- Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
- Keywords
- autoimmune gastritis, prevalence, parietal cell antibodies, intrinsic factor antibodies, atrophic gastritis, thyroid dysfunction, Hashimoto's thyroiditis, Graves' disease, Helicobacter pylori infection, health checkups
- MeSH terms
- Adult, Aged, Aged, 80 and over, Autoimmune Diseases, Female, Gastritis, Humans, Japan, Male, Middle Aged, Physical Examination, Prevalence, Helicobacter Infections, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.